Pharma Company Expands Capabilities with New Peptide Research Center
Pharma Company Expands Capabilities with New Peptide Research Center

Pharma Company Expands Capabilities with New Peptide Research Center

The company's Price-Earnings (PE) Ratio stands at 165.54.

DSIJ Intelligence-1 Article rating: 3.9

Major public shareholders include Tpg Asia Vii Sf Pte Ltd with 24.78 per cent, HBM Private Equity India with 1.99 per cent, Anitha Rudraraju Nandyala with 1.73 per cent, Raju Penmasta with 1.11 per cent and Penmasta Aruna with 1.02 per cent.

Can Sai Life Sciences ride the global CRDMO wave? A detailed IPO analysis
Can Sai Life Sciences ride the global CRDMO wave? A detailed IPO analysis

Can Sai Life Sciences ride the global CRDMO wave? A detailed IPO analysis

Sai Life Sciences Ltd, a prominent player in the CRDMO sector, is set to launch its IPO. Dive into the details of this ambitious offering, its financials, valuation, and whether it’s a wise investment for today’s market.

DSIJ Intelligence Article rating: 4.8

Sai Life Sciences Ltd, a prominent player in the CRDMO sector, is set to launch its IPO. Dive into the details of this ambitious offering, its financials, valuation, and whether it’s a wise investment for today’s market.

DSIJ MINDSHARE

Mkt Commentary25-Apr, 2025

Penny Stocks27-Apr, 2025

Mindshare26-Apr, 2025

Mindshare26-Apr, 2025

Mindshare26-Apr, 2025

Knowledge

MF22-Apr, 2025

MF17-Apr, 2025

General22-Mar, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR